IonQ reaches 1,000 patents milestone with new quantum computing grants
MGP Ingredients , Inc. (NASDAQ:MGPI) stock has faced significant headwinds, touching a 52-week low of $31.29. According to InvestingPro analysis, the stock appears undervalued at current levels, with a strong financial health score of "GOOD" and a robust current ratio of 5.91. The company, known for its distillery and ingredients solutions, has seen its shares tumble amidst a challenging market environment. Over the past year, MGPI has experienced a steep decline from its 52-week high of $92.52, with the 1-year change data reflecting a -63.37% drop. This downturn has brought the stock to its lowest price level in the last year, signaling a period of concern for investors who are closely monitoring the company’s performance and future outlook. Despite the decline, InvestingPro data shows the company has maintained dividend payments for 16 consecutive years, demonstrating financial resilience. Discover 10+ additional exclusive insights and detailed analysis in the Pro Research Report.
In other recent news, MGP Ingredients reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $1.56, exceeding the forecast of $1.50. Despite a 16% decrease in consolidated sales to $180.8 million, the company achieved a record cash flow from operations at $102.3 million for the year. The company recorded a net income loss of $42 million due to a significant non-cash goodwill adjustment. Looking ahead, MGP Ingredients provided guidance for 2025, anticipating net sales between $520 million and $540 million, with adjusted EBITDA projected between $105 million and $115 million. In another development, three members of MGP Ingredients’ Board of Directors, Donn Lux, Karen Seaberg, and Lori Mingus, plan to sell shares of the company’s common stock as part of their long-term financial strategies. These sales will be conducted through pre-established Rule 10b5-1 trading plans, which were initially adopted in March 2024. Despite these sales, the directors have expressed their continued commitment to the company’s strategic vision.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.